Foamix Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, New Jersey, June 1, 2017 /PRNewswire/ — Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, announced today that David Domzalski, President, will present a corporate overview and business update at the Jefferies 2017 Global Healthcare Conference, being held on June 6-9, 2017 at The Grand Hyatt in New York City.